| 发明名称 |
NKG2D MODULATION |
| 摘要 |
The present invention relates to methods and compositions for treating and/or preventing autoimmune and/or inflammatory disease. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells and/or NK cells, by modulating NKG2G. |
| 申请公布号 |
AT435656(T) |
申请公布日期 |
2009.07.15 |
| 申请号 |
AT20050761976T |
申请日期 |
2005.04.05 |
| 申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
发明人 |
LANIER, LEWIS;OGASAWARA, KOETSU;BLUESTONE, JEFFREY |
| 分类号 |
A61K38/17;A61K38/00;A61K39/395;A61P37/02;C07K16/28 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
